<DOC>
	<DOCNO>NCT01370265</DOCNO>
	<brief_summary>Blockage heart artery ( coronary artery disease ) lead angina ( chest pain ) , heart attack , heart failure , and/or death . Positron emission tomography ( PET ) stress myocardial perfusion imaging ( MPI ) powerful tool help identify blockage coronary artery . During PET MPI test , drug give mimic effect exercise heart . The study do measure blood flow heart use two similar drug approve mimic effect exercise heart people heart stress test . The first drug , call adenosine , approve use several decade . The second drug , call regadenoson , approve 2008 . The investigator look whether increase blood flow heart new drug ( regadenoson ) similar increase blood flow old drug ( adenosine ) . This information important use drug patient interpret blood flow value .</brief_summary>
	<brief_title>Myocardial Blood Flow PET N-13 Ammonia During Regadenoson v Adenosine Stress</brief_title>
	<detailed_description>The hypothesis study Regadenoson produce similar degree maximal hyperemia ( increase blood flow ) adenosine , vasodilator agent . There 2 day study subject . On Day 1 study , subject interview physical exam , include rest 12-lead electrocardiogram ( ECG ) exclude evidence silent ischemia myocardial infarction , cardiovascular disorder . Subjects instruct light meal least 4 hour prior PET MPI . Subjects instruct abstain caffeine-containing product 24 hour prior PET scan . Day 1 study occur less equal 4 week Day 2 . On Day 2 study , subject underwent three PET N-13 ammonia ( 10-20 mCi ) dynamic emission acquisition : resting , regadenoson ( 0.4 mg/5 mL IV ) , adenosine ( 140 microgram/kg/min ; order regadenoson v adenosine randomize accord subject 's birth year ) , three transmission acquisition attenuation correction . Each emission acquisition separate 50 min allow radioactive decay . At end drug infusion , subject monitor 5-30 min . Based know short biological half-lives stress agent , pharmacologic effect drug dissipate time next drug administer .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>Healthy male female volunteer age 30 . Written inform consent obtain subject . Each subject undergo history physical examination Any cardiovascular pulmonary symptom exam finding History low blood pressure ( &lt; 90/50 mmHg ) Prior cardiac history History hypertension History hyperlipidemia History diabetes mellitus History asthma chronic obstructive pulmonary disease Weight &gt; 450 pound Chronic kidney disease Other serious illness cancer Current smoking Medication use ( exception acetaminophen , aspirin , nonsteroidal antiinflammatory drug ( NSAIDs ) , thyroid hormone replacement ) Illicit drug use Prior allergic reaction adenosine , regadenoson , aminophylline Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Regadenoson ( Lexiscan )</keyword>
	<keyword>PET N-13 ammonia imaging</keyword>
	<keyword>Myocardial Blood Flow ( MBF )</keyword>
	<keyword>Regadenoson Stress</keyword>
</DOC>